Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers


AcelRx Stock Price Likely To Continue Climbling With FDA Approval Near

Jul 02 2014 @ 04:51
Summary AcelRx develops Zalviso to treat acute and breakthrough pain. We believe there is a 90% chance the company...

Why Is Activist Investor David Callan Accumulating Identiv Stock?

Jul 01 2014 @ 08:16
Summary These days we hear about shareholder activism almost daily. It is next to impossible to watch CNBC and not...

Volcano Corp Is Likely To Be Acquired

Jun 12 2014 @ 10:17
Summary In the area of acquisitions, we’ve had a solid history of very accurate behavior-based predictions...

Progenics Pharma's June 11th Adcom Likely To Attract Biotech Catalyst Traders

May 29 2014 @ 19:45
Progenics is expecting a Food and Drug Administration (FDA) Advisory Committee meeting on June 11 – 12 to...

Orexigen Poised to Move Higher On Drug Approval And Techincal Chart

May 27 2014 @ 18:14
Coming up on June 10th, 2014, Orexigen Therapeutics expects a Food and Drug Administration (FDA) for it’s weight...

Did Pozen Mislead Investors Concerning Its Recent FDA Rejection?

Apr 28 2014 @ 09:42
On Friday of last week, Pozen Inc.(POZN), received a CRL from the FDA, disallowing the New Drug Application (NDA...

High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued

Apr 01 2014 @ 09:18
Although we generally look for long plays in the biotechnology sector, certain macroeconomic factors can force us...

Biotech Catalyst Trade In Focus: Synthetic Biologics Upcoming Multiple Sclerosis Data Catalyst

Mar 10 2014 @ 02:27
Similar to how a blue-chip company might have an increase in stock price before an earnings call, small-cap...

Xenoport Gaining Momentum, Could It Be The Next Small Cap Biotech Flyer?

Feb 25 2014 @ 08:00
Xenoport (XNPT) focuses on developing and commercializing a portfolio of internally discovered product candidates...

Near Term Catalysts Should Propel Synergy's Share Price

Feb 19 2014 @ 08:00
Synergy Pharmaceuticals (SGYP) focuses on the development of drugs to treat gastrointestinal disorders and diseases...
  • Jump to a different page:
  • 1
  • 2
  • 3
  • ...
  • 7